It is tempting to speculate that CS-E treatment of breast cancer cells might identifiy similar Wnt/beta-catenin signaling thresholds, and therefore only affects a subset of Wnt/beta-catenin target genes and/or biological readouts. The gene discussed is CTNNB1; the disease is breast cancer.